Skip to content

A clinical study to check the safety and dandruff control of two hair care products

To evaluate and compare the in vivo safety and efficacy of two hair care formulations in terms of reduction in dandruff effect on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102172
Enrollment
72
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SCALP PRO DAILY ANTI DANDRUFF SHAMPOO (7B250258): The test product will be applied Thrice a week to Scalp and Hair shaft and rinsed off with water. The intervention will be continued f

Sponsors

Glenmark Pharmaceuticals Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian Asian male & females subjects. 2)Healthy subjects. 3)Skin is healthy on the studied anatomic unit 4)Having moderate to severe dandruff.

Exclusion criteria

Exclusion criteria: 1)For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2)Having refused to give his/her assent by not signing the consent form 3)Taking part in another study liable to interfere with this study 4)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area 5)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 6)Having a progressive asthma (either under treatment or last fit in the last 2 years) 7)Being epileptic 8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9)Having cutaneous hypersensitivity 10)Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months 12)Having changed his/ her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit 13)Having applied a hair care product on studied area the first day of the study (hair should be washed with the provided neutral shampoo two days prior to the day of visit.) 14)Having applied a hair care product on study visits (hair should be washed with the provided test product two days prior to the day of study visits.)

Design outcomes

Primary

MeasureTime frame
safety and reduction in dandruff effectTimepoint: Baseline, Day 7, Day 14, Day 28, Day 56

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026